Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Merkel Cell Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm
Neuroendocrine Neoplasm
Neuroendocrine Carcinoma
Extrapulmonary Neuroendocrine Carcinoma
Merkel Cell Carcinoma

Subtype

Merkel Cell Carcinoma

CI-CAN-00006016MCCExplore in graph →

51 active trials3 approved drugs2 evidence items

NCIt: C9231
OncoTree: MCC
DOID: 3965
UMLS CUI: C0007129
MeSH

Overview
Statistics
Survival
Genomics
Variants & evidence2
Drugs2
Trials133
Research
Rankings
Sources & provenance

D015266

Clinical trials

Registered studies

133 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 51
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

StatusAll Active (any)Completed 39 Recruiting 30 Active Not Recruiting 24 Terminated 24 Withdrawn 5 Not Yet Recruiting 5 Unknown 4 Available 1 Approved For Marketing 1

PhaseAll Early Phase 1 1 N/A 8 Phase 1 58 Phase 2 74 Phase 3 4

No study matches these filters